| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Product revenue | 86 | 0 | - | - |
| General and administrative | - | 8,187 | 7,731 | 5,952 |
| Cost of product revenue | 279 | - | - | - |
| Research and development | 11,393 | 12,088 | 10,313 | 7,703 |
| Selling, general and administrative | 8,781 | - | - | - |
| Total cost and expenses | 20,453 | 20,275 | 18,044 | 13,655 |
| Loss from operations | -20,367 | -20,275 | -18,044 | -13,655 |
| Interest income | 1,001 | 1,107 | 1,249 | 975 |
| Other expense | -19 | - | - | - |
| Total other income | 982 | 1,107 | 1,249 | 975 |
| Loss from operations, before income taxes | - | -19,168 | -16,795 | -12,680 |
| Income tax benefit | - | 0 | - | - |
| Net loss | -19,385 | -19,168 | -16,795 | -12,680 |
| Comprehensive loss | -19,385 | -19,168 | -16,795 | -12,680 |
| Net loss per share, basic and diluted (in dollars per share) | -0.29 | -0.28 | -0.25 | -0.21 |
| Weighted average common shares outstanding, basic and diluted (in shares) | 67,385,000 | 67,276,000 | 67,126,000 | 61,066,000 |
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)